Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma.
Chi AS, Cahill DP, Reardon DA, Wen PY, Mikkelsen T, Peereboom DM, Wong ET, Gerstner ER, Dietrich J, Plotkin SR, Norden AD, Lee EQ, Nayak L, Tanaka S, Wakimoto H, Lelic N, Koerner MV, Klofas LK, Bertalan MS, Arrillaga-Romany IC, Betensky RA, Curry WT, Borger DR, Balaj L, Kitchen RR, Chakrabortty SK, Valentino MD, Skog J, Breakefield XO, Iafrate AJ, Batchelor TT.
Chi AS, et al. Among authors: chakrabortty sk.
JCO Precis Oncol. 2020 Jun 8;4:PO.19.00295. doi: 10.1200/PO.19.00295. eCollection 2020.
JCO Precis Oncol. 2020.
PMID: 32923886
Free PMC article.